Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Experimental Nephrology
Literature
1.
Hisano S, Joh K, Katafuchi R, Shimizu A, Hashiguchi N, Kawamura T, Matsuo S. IgA Nephropathy Study Group in Japan. Reproducibility for pathological prognostic parameters of the Oxford classification of IgA nephropathy: a Japanese cohort study of the Ministry of Health, Labor and Welfare. Clin Exp Nephrol. 2017;21(1):92–6.CrossRefPubMed
2.
Sabour S. Comment on “Reliability of the modified tufts lumbar degenerative disc classification between neurosurgeons and neuroradiologists”—a statistical issue to avoid mismanagement. J Clin Neurosci. 2016;34:303.CrossRefPubMed
3.
4.
Sabour S. Spinal instability neoplastic scale: methodologic issues to avoid misinterpretation. AJR Am J Roentgenol. 2015;204(4):W493.CrossRefPubMed
5.
Sabour S. Reliability of the ASA physical status scale in clinical practice: methodological issues. Br J Anaesth. 2015;114(1):162–3.CrossRefPubMed
Metadata
Title
Reproducibility for pathological prognostic parameters of the Oxford classification of IgA nephropathy: statistical issue
Authors
Siamak Sabour
Maryam Majidi
Publication date
01-12-2017
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 6/2017
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-017-1421-x

Other articles of this Issue 6/2017

Clinical and Experimental Nephrology 6/2017 Go to the issue

Images in nephrology

Testicular angina in a hemodialysis patient: expect the unexpected

Acknowledgment

List of referees

Erratum

Erratum to: Impact of hemoglobin levels on renal and non-renal clinical outcomes differs by chronic kidney disease stages: the Gonryo study

Original article

Long-term treatment with EGFR inhibitor erlotinib attenuates renal inflammatory cytokines but not nephropathy in Alport syndrome mouse model

Original Article

Thyrotropin levels are associated with chronic kidney disease among healthy subjects in cross-sectional analysis of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)

Review article

Current pathological perspectives on chronic rejection in renal allografts

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits